Vaccines: predicting the risk of allergy and autoimmunity (Q34612433)

3 August 2017

1 reference

title

Vaccines: predicting the risk of allergy and autoimmunity (English)

1 reference

3 August 2017

Descotes J

1

1 reference

3 August 2017

Ravel G

series ordinal

2

1 reference

3 August 2017

Ruat C

series ordinal

3

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

174

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

45-51

1 reference

Molecular mimicry and autoimmunity.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900056-2

7 January 2021

Allergic mechanisms and urticaria/angioedema after hepatitis B immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900056-2

7 January 2021

The Vaccine Adverse Event Reporting System (VAERS)

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900056-2

7 January 2021

Value of animal models for predicting hypersensitivity reactions to medicinal products

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900056-2

7 January 2021

The timing of immunization affects the development of diabetes in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900056-2

7 January 2021

Autoimmunity and toxicity testing

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900056-2

7 January 2021

The popliteal lymph node assay in 1996.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900056-2

7 January 2021

Etiology and pathogenesis of a spontaneous lupus-like syndrome in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900056-2

7 January 2021

Treatment Of NZB/NZW F1 Hybrid Mice withMycobacterium Bovis Strain BCG or Type II Interferon Preparations Accelerates Autoimmune Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900056-2

7 January 2021

Arthus reaction to recombinant hepatitis B virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900056-2

7 January 2021

Lupus vulgaris following bacille Calmette-Guérin vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900056-2

7 January 2021

Immunisation and type 1 diabetes mellitus: is there a link?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900056-2

7 January 2021

Vaccine-induced autoimmunity in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900056-2

7 January 2021

Demyelinating disease and hepatitis B vaccination: is there a link?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900056-2

7 January 2021

The local lymph node assay and potential application to the identification of drug allergens

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900056-2

7 January 2021

The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900056-2

7 January 2021

Animal models of human disease. Transgenic and knockout models of autoimmunity: Building a better disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900056-2

7 January 2021

Animal models of systemic vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900056-2

7 January 2021

The relevance of TH1 and TH2 cells in immediate and nonimmediate reactions to gelatin-containing vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900056-2

7 January 2021

Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900056-2

7 January 2021

Anaphylaxis to the 23-valent pneumococcal vaccine in child: a case-control study based on immediate responses in skin tests and specific IgE determination

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900056-2

7 January 2021

Vaccination and autoimmunity-'vaccinosis': a dangerous liaison?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900056-2

7 January 2021

Stimulation of the developing immune system can prevent autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900056-2

7 January 2021

Can immunisation trigger rheumatoid arthritis?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900056-2

7 January 2021

Epidemiology faces its limits.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900056-2

7 January 2021

The risk of Guillain-Barré syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900056-2

7 January 2021

Autoantibodies in conventional toxicity testing

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900056-2

7 January 2021

10.1016/S0300-483X(02)00056-2

Identifiers

DOI

1 reference

3 August 2017

1 reference